• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
75,527.95 1,695.40
( 2.30%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
66,063.56 1,846.29
(2.88%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

GTL Infrastructure Ltd
Industry :  Transmisson Line Towers / Equipment
BSE Code
ISIN Demat
Book Value()
532775
INE221H01019
-4.0713425
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GTLINFRA
0
1934.18
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

Balaxi Pharmaceuticals consolidated net profit declines 92.94% in the March 2026 quarter
May 29,2026
Net profit of Balaxi Pharmaceuticals declined 92.94% to Rs 0.61 crore in the quarter ended March 2026 as against Rs 8.64 crore during the previous quarter ended March 2025. Sales declined 7.29% to Rs 70.71 crore in the quarter ended March 2026 as against Rs 76.27 crore during the previous quarter ended March 2025.

For the full year,net profit declined 94.34% to Rs 1.42 crore in the year ended March 2026 as against Rs 25.07 crore during the previous year ended March 2025. Sales declined 7.65% to Rs 270.17 crore in the year ended March 2026 as against Rs 292.56 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales70.7176.27 -7 270.17292.56 -8
OPM %0.1716.45 -3.1612.72 -
PBDT2.0510.12 -80 7.4530.56 -76
PBT1.409.66 -86 5.2928.67 -82
NP0.618.64 -93 1.4225.07 -94